Physician profile
Bart Carter
NPI 1396138657
$2,759.20
in general payments reported to CMS, 2019-2025
9 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what 93% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $180 · 2021: $237 · 2022: $112 · 2023: $514 · 2024: $166 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857 · Consulting Fee: $530 · Travel and Lodging: $509 · Education: $325 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.68 |
| Consulting Fee | $530.00 |
| Travel and Lodging | $509.18 |
| Education | $324.63 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,363.63 | 2020-2025 | Invisalign, Itero, Vivera Retainers |
| Ormco Corporation | $149.77 | 2021-2023 | Spark, Damon |
| 3m Company | $63.12 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $54.63 | 2024 | |
| American Orthodontics Corporation | $32.32 | 2025 | Master Series, Radiance, Empower-Ceramic |
| Solventum Corporation | $32.31 | 2024-2025 | |
| Nobel Biocare USA | $28.56 | 2023 | Nobelactive |
| Envista Holdings Corporation | $22.07 | 2024 | Spark |
| Patterson Companies, INC. | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.